In the most recent issue of JAMA, Journal of the American Medical Association, Arthur M. Feldman, MD, PhD, TUSMs Executive Dean, and Verdi J. DiSesa, MD, MBA, TUSMs Vice Dean of Clinical Affairs, contend that the creation of regional centers of excellence would ensure the quality of transcatheter aortic valve replacement (TAVR), a treatment approved by the FDA for inoperable or high risk patients with aortic valve stenosis. Learn more at the link below.
Posted on: Mon, 12 May 2014 18:53:43 +0000
Trending Topics
Recently Viewed Topics
© 2015